Dizygotic twin sisters with normosmic idiopathic hypogonadotropic hypogonadism caused by an FGFR1 gene variant
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Isolated hypogonadotropic hypogonadism (IHH) is a rare genetic disorder that is clinically and genetically heterogeneous. It is characterized by absent or incomplete pubertal development owing to an isolated defect in the production, secretion, or action of gonadotropin-releasing hormone. The incidence of IHH is estimated at 1:30,000 in males and 1:125,000 in females. Although the vast majority of IHH cases are sporadic, some X-linked recessive, autosomal dominant, and autosomal recessive modes of inheritance have been described. IHH can be classified into Kallmann syndrome with anosmia and normosmic IHH. Here, we report dizygotic twin sisters with normosmic IHH who showed short stature and absence of puberty as a result of a variant of the FGFR1 gene. They had a normal sense of smell, and brain magnetic resonance imaging (MRI) showed well-defined olfactory bulbs. The older sister and the twins' mother had cleft palate, while the younger sister did not. The mother had menarche at the age of 16 years after hormonal replacement owing to delayed puberty. Molecular analysis of the FGFR1 gene identified a missense variant c.874C>G (p.His292Asp) in the twins and their mother. Herein, we described the clinical heterogeneity observed in the 2 affected twins who carry an identical variant in the FGFR1 gene. Further studies of the effects of modifier genes and epigenetic factors on the expression of FGFR1, as well as the various clinical manifestations of its mutations, are warranted.
Abstract
Isolated hypogonadotropic hypogonadism (IHH) is a rare genetic disorder that is clinically and genetically heterogeneous. It is characterized by absent or incomplete pubertal development owing to an isolated defect in the production, secretion, or action of gonadotropin-releasing hormone. The incidence of IHH is estimated at 1:30,000 in males and 1:125,000 in females. Although the vast majority of IHH cases are sporadic, some X-linked recessive, autosomal dominant, and autosomal recessive modes of inheritance have been described. IHH can be classified into Kallmann syndrome with anosmia and normosmic IHH. Here, we report dizygotic twin sisters with normosmic IHH who showed short stature and absence of puberty as a result of a variant of the FGFR1 gene. They had a normal sense of smell, and brain magnetic resonance imaging (MRI) showed well-defined olfactory bulbs. The older sister and the twins' mother had cleft palate, while the younger sister did not. The mother had menarche at the age of 16 years after hormonal replacement owing to delayed puberty. Molecular analysis of the FGFR1 gene identified a missense variant c.874C>G (p.His292Asp) in the twins and their mother. Herein, we described the clinical heterogeneity observed in the 2 affected twins who carry an identical variant in the FGFR1 gene. Further studies of the effects of modifier genes and epigenetic factors on the expression of FGFR1, as well as the various clinical manifestations of its mutations, are warranted.
참고문헌 (20)
- Bianco SD, "The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism", Nat Rev Endocrinol, 5, pp.569~576 (2009)
- Iovane A, "New insights in the genetics of isolated hypogonadotropic hypogonadism", Eur J Endocrinol, 151(Suppl 3), pp.U83~U88 (2004)
- Topaloglu AK, "Update on the genetics of idiopathic hypogonadotropic hypogonadism", J Clin Res Pediatr Endocrinol, 9, pp.113~122 (2017)
- Sun-Jeong Shin, "Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience", Annals of Pediatric Endocrinology & Metabolism, 20(1), pp.27~33 (2015), 대한소아내분비학회
- Mitchell AL, "Genetic basis and variable phenotypic expression of Kallmann syndrome : towards a unifying theory", Trends Endocrinol Metab, 22, pp.249~258 (2011)
- Seminara SB, "Genetics of hypogonadotropic hypogonadism", J Endocrinol Invest, 23, pp.560~565 (2000)
- Beate K, "Genetics of isolated hypogonadotropic hypogonadism : role of GnRH receptor and other genes", Int J Endocrinol, 2012, pp.147893~ (2012)
- Laitinen EM, "Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland", Orphanet J Rare Dis, 6, pp.41~ (2011)
- Silveira LF, "Approach to the patient with hypogonadotropic hypogonadism", J Clin Endocrinol Metab, 98, pp.1781~1788 (2013)
- Cho JH, "The Korean version of the Sniffin' stick (KVSS) test and its validity in comparison with the cross-cultural smell identification test (CC-SIT)", Auris Nasus Larynx, 36, pp.280~286 (2009)
- Sam S, "Normal physiology of hypothalamic pituitary regulation", Endocrinol Metab Clin North Am, 37, pp.1~22 (2008)
- Crowley WF Jr, "The physiology of gonadotropin-releasing hormone (GnRH)secretion in men and women", Recent Prog Horm Res, 41, pp.473~531 (1985)
- Hoffman AR, "Induction of puberty in men by long-term pulsatile administration of lowdose gonadotropin-releasing hormone", N Engl J Med, 307, pp.1237~1241 (1982)
- Crowley WF Jr, "New genes controlling human reproduction and how you find them", Trans Am Clin Climatol Assoc, 119, pp.29~37 (2008)
- Pitteloud N, "Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes", Mol Cell Endocrinol, 254-255, pp.60~69 (2006)
- Trarbach EB, "Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia", J Clin Endocrinol Metab, 91, pp.4006~4012 (2006)
- Xu N, "A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism", J Clin Endocrinol Metab, 92, pp.1155~1158 (2007)
- Raivio T, "Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism", J Clin Endocrinol Metab, 94, pp.4380~4390 (2009)
- Tsai PS, "Mechanisms of disease : insights into X-linked and autosomal-dominant Kallmann syndrome", Nat Clin Pract Endocrinol Metab, 2, pp.160~171 (2006)
- Boehm U, "Expert consensus document : European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment", Nat Rev Endocrinol, 11, pp.547~564 (2015)